979
Views
181
CrossRef citations to date
0
Altmetric
Research Article

Chromobacterium violaceum: A Review of Pharmacological and Industiral Perspectives

&
Pages 201-222 | Published online: 29 Sep 2008

REFERENCES

  • Aldridge, K.E., Valainis, G.T., and Sanders, C.V., Comparison of the in vitro of citoprofloxacin and 24 other antimicrobial agents against clinical strains of Chromobac-terium violaceum, Diagnostic Microbiol. Infect. Dis. 10, 31–39, 1988).
  • Antônio, R.V., Violacein biosynthesis by Chromobacterium violaceum: Synthesis and biological activities of a probable intermediate (Durán, N.and Haun M. Supervisors), Ph.D. Dissertation, Biology Institute, Universidade Estadual de Campinas, Brazil, 1994.
  • Audebaud, G., Ganzin, M., Ceccaldi, J., and Merveille, P., Isolement dun Chromo-bacterium violaceum a partir de lessions hepatiques observees chez un singe Cercop-ithecus cephus etude et pouvoir pathogene, Ann. L´Institute Pasteur. 87, 413–417, 1954.
  • August, P.R., Grossman, T.H., Minor, C., Draper, M.P., MacNeil, I.A., Pemberton, J.M., Call, K.M., Holt, D., and Osburne, M.S., Sequence analysis and functional characterization of the violacein biosynthetic pathway from Chromobacterium violaceum, J. Mol. Microbiol. Biotechnol. 2, 513–519, 2000.
  • August, P.R., Grossman, T.H., Minor, C., Draper, M.P., MacNeil, I.A., Pemberton, J.M., Call, K.M., Holt, D., and Osburne, M.S., Hydroxylases VioABCD in Chromobacterium violaceum, NCBI-Protein. AAD51809-51811, 2000.
  • Bachofen, R.and Schenk, A., Quorum sensing autoinducers: Do they play a role in natural microbial habitats?, Microbiol. Res. 153, 61–63, 1998.
  • Ballantine, J.A., Beer, R.J.S., Crutchley, D.J., Dodd, G.M., and Palmer, D.R., The synthesis of violacein and related compounds, J. Chem. Soc. 232-233, 1958.
  • Ballantine, J.A., Beer, R.J.S., Crutchley, D.J., Dodd, G.M., and Palmer, D.R., The chemistry of bacteria. Part VIII. The synthesis of violacein and related compounds, J. Chem. Soc. 2292-2299, 1960.
  • Balows, A., Truper, H.G., Dworkin, M., Harder, W., Schleifer, K.H. The prokaryots. Vol. III, 2nd. ed. Springer-Verlag N.Y., 1992.
  • Bazylinski, D.A., Palome, E., Blakemore, N.A., and Blakemore, R.P., Denitrification by Chromobacterium violaceum, Appl. Environ. Microbiol. 52, 696–699, 1986.
  • Beinert, H., Copper in biological system. A report from 6th. Manziana Conference, J. Inorg. Biochem. 44, 173–218, 1991.
  • Bergonzini, C., Um nuevo bacterio colorato, Ann. Soc. Natural. Modena. Ser.2, 14, 149–158, 1881.
  • Blereau, R.P., Septicemia and death caused by Chromobacterium violaceum, Southern Med. J. 73, 1093–1094, 1980.
  • Bilton, B.D. and Johnson, L.W., Recurrent nonfatal Chromobacterium violaceum infection in a nonimmunocompromised patient, Infect. Med. 17, 686–690, 2000.
  • Blosser, R.S., and Gray, K.M., Extraction of violacein from Chromobacterium violaceum provides a new quantitative bioassay for N-acyl homoserine lactone autoinducers, J. Microbiol. Methods. 40, 47–55, 2000.
  • Boisbaudran, L., Matière colorante se formant dans la colle de farine, Comp. Rend. Acad. Sci. 94, 562–563, 1882.
  • Bromberg, N., Violacein biotransformations, (Durán, N., Supervisor). M.Sc. Thesis, Chemistry Institute, Universidade Estadual de Campinas, Brazil, 2000.
  • Buchanan, E., Studies in the nomenclature and classification of the bacteria, J. Bacteriol. 3, 52–57, 1918.
  • Byrd, J.C., Shinn, C., Ravi, R., Willis, C.R., Waselenko, J.K., Flinn, I.W., Dawson, N.A., and Grever, M.R., Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells, Blood. 94, 1401–1408, 1999.
  • Byrd, J.C., Waselenko, J.K., Keating, M., Rai, K., and Grever, M.R., Novel therapies for chronic lymphocytic leukemia in the 21st century, Seminar Oncol. 27, 587–597, 2000.
  • Caldas, L.R., Photochemistry and photobiology in a virgin land, Photochem. Photobiol. 26, 1–2, 1977.
  • Caldas, L.R., Um pigmento nas águas negras, Ciência Hoje 11, 56–57, 1990.
  • Caldas, L.R., LeitãoA.A.C., Santos, S.M., and Tyrrell, R.M. Preliminary experiments on the photobiological properties of violacein, Intern. Symp. Curr. Topics Radiol. Photobiol. Acad. Brasil. Cienc. Rio de Janeiro, 121-132, 1978.
  • Carrasco, L., Astorga, R., Mendez, A., Maldonado, A., Barazona, J., and Perea, A., Acute pleuropneumonia in Barbary sheep (Amnotragus lervia) asociated with Chromo-bacterium violaceum, Veterin. Record. 138, 499–500, 1996.
  • Cha, C., Gao, P., Chen, Y.C., Shaw, P.D., and Farrand, S.K., Production of acyl-homoserine lactone quorum-sensing signals by Gram-negative plant-associated bacteria, Mol. Plant Microbe Interact. 11, 1119–1129, 1998.
  • Chong, C.Y. and Lam, M.S., Case report and review of Chromobacterium sepsis-a Gram negative sepsis mimicking melioidosis, Singapore Med.J. 38, 263–265, 1997.
  • Cheah, E., MacPherson, K., Quiggin, D., Keese, P., and Ollis, D.L., Crystallization and preliminary X-ray analysis of IND, an enzyme with indole oxygenase activity from Chromobacterium violaceum, Acta Crystl. Sec.D.Biol. Crystal. 54, 657–658, 1998.
  • Chen, D.W. and Frey, P.A., Phenylalanine hydroxylase from Chromobacterium violaceum. Uncoupled oxidation of tetrahydropterin and the role of iron in hydroxylation, J. Biol. Chem. 273, 25594–25601, 1998.
  • Chernin, L.S., Winson, M.K., Thompson, J.M., Haran, S., Bycroft, B.W., Chet, I., Williams, P., and Stewart, G.S.A.B., Chitinolytic activity in Chromobacterium violaceum: substrate analysis and regulation by quorum sensing, J. Bacteriol. 180, 4435–4441, 1998.
  • Christian, M.C., Pluda, J.M., Ho, P.T.C., Arbuck, S.G., Murgo, A.J., and Sausville, E.A., Promising new agents under development by the division of cancer treatment, diagnosis, and centers of the National Cancer Institute, Seminars Oncol. 24, 219–240, 1997.
  • Cimarusti, C., Floyd, D.M., Fritz, A.W., Parker, W.L., Stusarchyk, W.A., and Sykes, R.B., US Patent. US4386034-A, 1983.
  • Collins, B., Kollias, G., Battles, A., and Moreland, A., Chromobacterium violaceum infection in a stumptailed monkey (Macaca artoices), Lab. Animal Sci. 35, 530–531, 1985.
  • Cooper, R., Wells, J.S., and Sykes, R.B., Novel potentiators of ?-lactam antibiotics. Isolation of SQ28, 504 and SQ28, 546 from Chromobacterium violaceum, J. Antibiotics. 38, 449–454, 1985.
  • Cooper, R., Sykes, R.B., and Wells, J.S., New compounds, SQ28504 and SQ28546 — enhance antibacterial activity of beta-lactam antibiotics SQ28546, US Patent US4752469-A, 1984.
  • De Azevedo, M.B.M., Alderete, J., Lino, A.C.S., Loh, W., Faljoni-Alario, A., and Durán, N., Violacein/cyclodextrin inclusion complex by diffusion coefficient and circular dichroism measurements, J. Inclusion Phenom. Mol. Recognit. Chem. 37, 67–74, 2000.
  • De Azevedo, M.B.M., Alderete, J., Rodriguez, J.A., De Souza, A.O., Faljoni-Alario, A., and Durán, N., Biological activities of new antitu-moral of indole derivatives in a inclusion complex with cyclodextrin, J. Inclusion Phenom. Mol. Recognit. Chem. 37, 93–101, 2000.
  • De Azevedo, M.B.M., Justo, G.Z., Rettori, D., Rodriguez, J.A., Haun, M., and Durán, N., Antioxidant activity of an inclusion complex of violacein and ?-cyclodextrin, Proc. Intern. Symp. Control. Rel. Bioact. Mater. 27, 506–507, 2000.
  • De Azevedo, M.B.M., Melo, P.S., Almeida, A.B.A., Souza-Brito, A.R.M., Haun, M., and Durán, N., Antiulcerogenic activity of violacein/cyclodextrin inclusion complexes and violacein, Proc. Intern. Symp. Control. Rel. Bioact. Mater. 27, 508–509, 2000.
  • De Moss, R.D., Violacein, Antibiotics, 2, 77–81, 1967.
  • De Moss, R.D. and Evans, N.R., Physiological aspects of violacein biosynthesis in nonproliferating cells, J. Bacteriol. 78, 583–588, 1959.
  • De Moss, R.D. and Evans, N.R., Incorporation of C14-labeled substrates into violacein, J. Bacteriol. 79, 729–733, 1960.
  • De Souza, A.O., Aily, D.C.G., Sato, D.N., and Durán, N., Atividade da violaceina in vitro sobre o Mycobacterium tuberculosis H37RA, Rev. Inst. Adolfo Lutz. 58, 59–62, 1999.
  • Dewhirst, F.E., Paster, B.J., and Bright, P.L., Chromobacterium, Eikenella, Kingella, Neisseria, Simonsiella, and Vitreoscilla species comprise a major branch of the beta group proteobacteria by 16S ribosomal ribonucleic acid sequence comparison: Transfer of Eikenella and Simonsiella to the family Neisseriaceae (emend.), Intern.J.System. Bacteriol. 39, 258–266, 1989.
  • Dewhirst, F.E., Paster, B.J., and Bright, P.L., Chromobacterium violaceum 16S ribosomal RNA, complete cds, NCBI-Nucleotide.M22510, 1989.
  • Durán, N., Violaceina: a descoberta de um antibiótico, Ciencia Hoje. 11, 58–80, 1990.
  • Durán, N., Antonio, R.V., Haun, M., and Pilli, R.A., Biosynthesis of trypanocide by Chromobacterium violaceum, WorldJ.Microbiol. Biotechnol. 10, 686–690, 1994.
  • Durán, N. and Bromberg, N., Violacein transformation by peroxidase and oxidases: Implications on its biological properties, J. Mol. CatalysisB.Enzym. 11, 463-467, 2001.
  • Durán, N., De Azevedo, M.B.M., and Alderete, J. Formulation process of cyclodextrin/violacein for using as antibacterial, antitumoral, antiviral and trypanocide, Brazilian Patent PIBr 9801307, 1998.
  • Durán, N., De Conti, R., Sato, L.M., Jardim, L.S.A., and Moraes, S.G., Process for the synthesis of indole-glycosides, Brazilian Patent. PIBr. 9702822, 1997.
  • Durán, N., Erazo, S., and Campos, V., Bacterial chemistry-II: Antimicrobial photoprod-uct from pigment of Chromobacteriumviolaceum, An. Acad. Brasil. Cienc. 55, 231–234, 1983.
  • Durán, N., Campos, V., Riveros, R., Joyas, A., Pereira, M.F., and Haun, M., Bacterial chemistry. III. Preliminary studies on trypanosomal activities of Chromobacterium violaceum products, An. Acad. Brasil. Sci. 61, 31–36, 1989.
  • Durán, N. and Faljoni-Alario, A., Bacterial chemistry-I: studies of a potential phototherpaeutic substance from Chromobacterium violaceum, An. Acad. Brasil. Ciênc. 52, 297–302, 1980.
  • Durán, N. and Haun, M., Trypanocide. State of art, Mem. Inst. Oswaldo cruz. Suppl. I 86, 29–30, 1991.
  • Durán, N. and Haun, M., Production process of preparation and purification of antitumoral 3-[1, 2-dihydro-5-(5-hydroxy-1H-indol-3-yl)-2-oxo-3H-pyrrol-3-ylidene]-1, 3-dihydro-2H-indol-2-one, Brazilian Patent PIBr. 9702918, 1997.
  • Durán, N., Jardim, L.M., Moraes, S.G., and De Conti, R. Nuevo metodo de sintesis de N-indol-glicosideos com actividad antimicrobiana, Rev. Soc. Quim. Chile. 43, 91–96, 1998.
  • Durán, N., Melo, P.S., and Haun, M., Violacein in an investigational AIDS-related lymphoma screen in vitro, Proc. VIII National Meeting of Virology, São Lorenço M.G. Brazil, H54, 179, 1996.
  • Durán, N., Melo, P.S., and Haun, M., In vitro evaluation of violacein on AIDS-related lymphoma and human tumor cells lines, XXI National Meeting Biochemical Society-SBBq, Caxambu M.G. Brazil, 0-24, 1996.
  • Durán, N., Riveros, R., Haun, M., Da Silva, L.P., Hoffman, M.E., Dawood, F.A.M., Pizani, O.D.S., Nunes, O.D.S., Campos, V., and Joyas, A., Chemistry, biochemistry and clinical aspects of a microbiological new compounds, Proc. VI Bioorganic Workshop (Brazil-Chile), Santiago, Chile, 14-16, 1988.
  • Durán, N. and De Souza, A.O., “Process for the violacein application as antimycobacterial agent, Brazilian Patent. PIBr, in press, 2001.
  • Farrar, W.E. and O’Dell, N.M., ?-Lactamase activity in Chromobacterium violaceum, J. Infect. Dis. 134, 290–293, 1976.
  • Farrell, K., Vanwerkhooven, M., Gratten, M., and Aiken, G.H. Chromobacterium violaceum infection: Report of a fatal case, Papua New Guinea Med.J. 22, 94–95, 1979.
  • Feldman, R.B., Stern, G.A., and Hood, C.I., Chromobacterium violaceum infection of the eye: A report of 2 cases, Arch. Ophthalmol. 102, 711–713, 1984.
  • Fujisawa, H.and Nakata, H., Phenylala-nine 4-monooxygenase from Chromobacte-rium violaceum, Methods Enzymol. 142, 44–49, 1987.
  • Fujita, T., Goto, T., Hori, Y., Okuhara, M., Shigematsu, N., and Ueda, H., New antibiotic substance for FR901228 obtained by culture of Chromobacterium violaceum WB 968, and biologically pure culture of this microorganism, Eur.Patent EP352646-A; US4977138A, 1990.
  • Fombuena, M.Ballester, J.E., Pedro, F., Garcia del Toro, M., and Herrera Ballester, A. Infection by Chromobacterium violaceum in a patient with acquire immunodeficiency virus infection. Enferm. Infect. Microbiol. Clin. 16, 46–47, 1998.
  • Gaeumann, E., Prelog, V., Bickel, H., and Vischer, E., Growth accelerators, ferrioxamine. Ger Patent. Ger 1123436, 1962.
  • Genet, R., Benetti, P.H., Hammadi, A., and Menez, A., L-Tryptophan 2´, 3´-oxidase from Chromobacterium violaceum, J. Biol. Chem. 270, 23540–23545, 1995.
  • Geoghiou, P.R., Okane, G.M., Siu, S., and Kemp, R.J., Near-fatal septicemia with Chro-mobacterium violaceum, Med.J.Austr. 150, 720–721, 1989.
  • Gillis, M.and De Ley, J., The genera Chro-mobacterium and Janthinobacterium, In: The Prokaryotes, Vol.3, ( Ballow A. , et al., Eds., 2nd ed.) Springer-Verlag N.Y. , Chap. 133, 2591-2600, 1992.
  • Gogolewski, R.P., Chromobacterium violaceum septicemia in a dog, Austr. Veter.J. 60, 226–226, 1983.
  • Gourson, C., Benhaddou, R., Granet, R., Krausz, P., Verneuil, B., Branland, P., Chauvelon, G., Thibault, J.F., and Saulnier, L., Valorization of maize bran to obtain biodegradable plastic films, J. Appl. Poly. Sci. 74, 3040–3045, 1999.
  • Groves, M.G., Strauss, J.M., Abbas, J., and Davis, C.E., Natural infections of Gibbons with s bscterium producing violet pigment (Chromobacterium violaceum), J. Infect. Dis. 120, 605–607, 1969.
  • Hamada, M., Kondo, S., Nakamura, H., Ikeda, T., Ikeda, D., Iinuma, K., Gomi, S., Ikeda, Y., and Takuchi, T., A new antibiotic, 3, 6-dihydroxyundoxazene, J. Antibiotics. 36, 445–447, 1983.
  • Hammadi, A., Menez, A., and Genet, R., Asymmetric deuteration of N-acetyl-(Z)-?, ?-dehydrotryptophan-(L)-phenylalanine methyl ester produced by (L)-tryptophan 2´, 3´-oxidase from Chromobacterium violaceum. A new route for stereospecific labelling of peptides, Tetrahedron 53, 16115–16122, 1997.
  • Hassan, H., Suntharalingam, S., and Dhillon, K.S., Fatal Chromobacterium violaceum septicemia, Singapore Med.J. 34, 456–458, 1993.
  • Harmsen, D.and Singer, C., Chromobacte-rium violaceum 16S and 23S rRNA gene, NCBI-Nucleotide. AF124618; AJ247211 (1999).
  • Haun, M., Pereira, M.F., Hoffman, ME., Joyas, A., Campos, V., Filardi, L.D., De Castro, S.L., and Durán, N., Bacterial chemistry. VI. Biological activities and cytotoxic-ity of 1, 3-dihydro-2H-indol-2-one derivatives, Biol. Res. 25, 21–25, 1992.
  • Higaki, T., Nagao, K., Isogo, S., Kanda, M., Fujita, K., and Yamashita, M., Antitumoric antibiotic WB968 manufacture with Chromobacterium, Jpn. Kokai Tokkyo Koho. Jp. 090311088 A2, 1997. Chem. Abstr. 126, 250252, 1998.
  • Hiraoka, N., Yoshioka, K., Inoue, K., Kawahito, Y., and Kasamatsu, Y., Chro-mobacterium violaceum sepsis accompanied by bacteria-associated hemophagocytic syndrome in a Japanese man, Arch. Intern. Med. 159, 1623–1624, 1999.
  • Holt, J.G. and Krieg, N.R. (Eds), Bergey’s Manual of Systematic Bacteriology, Vol 1, 72. Williams & Wilkins, Baltimore, 580-582, 1984.
  • Hoshino, T., Chromobacterium violaceum-violacein biosynthetic gene cluster (VioABCD), NCBI-Protein. BAA84782-84785; AF172851; AB032799, 1999.
  • Hoshino, T., Kondo, T., Uchiyama, T., and Ogasawara, N., Biosynthesis of violacein: A novel rearrangement in tryptophan metabolism with a 1, 2-shift of the indole ring, Agric. Biol. Chem. 51, 965–968, 1987.
  • Hoshino, T., Takano, T., Hori, S., and Ogasawara, N., Biosynthesis of violacein: Origins of hydrogen, nitrogen and oxygen atoms in the 2-pyrrolidone nucleous, Agric. Biol. Chem. 51, 2733–2741, 1987.
  • Hoshino, T., Kojima, Y., Hayashi, T., Uchiyama, T., and Kaneko, K., A new metabolite of tryptophan, chromopyrrolic acid, produced by Chromobacterium violaceum, Biosci. Biotechnol. Biochem. 57, 775–781, 1993.
  • Hoshino, T., Hayashi, T., and Odajima, T., Biosynthesis of violacein.1. oxygenation at the 2-position of the indole ring and structures of proviolacein, prodeoxyviolacein and pseudoviolacein, the plausible biosynthetic intermediates of violacein and deoxyviolacein, J. Chem. Soc. Perkin Trans. 1. 1565-1571, 1995.
  • Hoshino, T.and Ogasawara, N., Biosynthesis of violacein: Evidence for the interme-diacy of 5-hydroxy-L-tryptophan and structure of a new pigment, oxyviolacein, produced by the metabolism of 5-hydroxytryptophan, Agric. Biol. Chem. 54, 2339–2346, 1990.
  • Hoshino, T., Hayashi, T., and Uchiyama, T., Pseudodeoxyviolacein, a new red pigment produced by tryptophan metabolism of Chro-mobacterium violaceum Biosci. Biotechnol. Biochem. 58, 279–282, 1994.
  • Hoshino, T., Kimura, K., Takahashi, H., Uchiyama, T., and Yoshihama, M., New bis:indole-pyrrole derivatives obtained from Chromobacterium violaceum — has good antitumor and antimicrobial properties, and low toxicity, Eur. Pat. Appl. EP612, 742, 1994.
  • Huffam, S.E., Nowotny, M.J., and Currier, B.J., Chromobacterium violaceum in tropical northern Australia, Med.J.Austr. 168, 335–337, 1998.
  • Huisman, G.W., Peoples, O.P., and Skraly, F., Microbes with polyhydroxyalkanoates (PHA) biosyntheis genes integrated into their chromosome and method for producing PHAs and screening for PHA genes, PCT Int. Appl. WO 2000011188 A1, 2000. Chem. Abstr. 132, 205399, 2000.
  • Johnson, W.M., Disalvo, A.F., and Steuer, R.R., Fatal Chromobacterium violaceum sep-ticemia, Am.J.Clin. Pathol. 56, 400–403, 1971.
  • Kaufman, S.C., Ceraso, D., and Schugurensky, A., First case report from Argentina of fatal sep-ticemia caused by Chromobacterium violaceum, J. Clin. Microbiol. 23, 956–958, 1986.
  • Kim, T.H., and Yu, T.S., Chemical modification of extracellular cytosine deaminase from Chromobacterium violaceum YK 391, J. Microbiol. Biotechnol. 8, 581–587, 1998.
  • Kleid, D.G., Kohr, W.J., and Thibodeau, F.R., Recovering gold from gold ore or carbonaceous gold, using microorganisms which produce cyanide ion or which degrade cyanide ion, Can. Pat. Appl. CA 2030900 AA, 1991. Chem. Abstr. 115, 187196, 1997.
  • Kolibachuk, D., Miller, A., and Dennis, D., Cloning, molecular analysis, and expression of the polyhydroxyalkanoic acid synthase (phaC) gene from Chromobacterium violaceum, Appl. Environ. Microbiol. 65, 3561–3565, 1999.
  • Kolibachuk, D.and Dennis, D., Chromo-bacterium violaceum SoxR homolog gene, complete cds, NCBI-Protein. AAC69613; AF061445, 1998.
  • Kolibachuk, D., Miller, A., and Dennis, D., Chro-mobacterium violaceum polyhydroxyalkanoate syn-thase (phaC) gene, complete cds; 3-ketothiolase (phaA) gene, partial cds; and unknown gene, NCBI-Protein AAC69614-AAC69616; AF061446, 1999.
  • Kornegay, R.W., Pirie, G., Brown, C.C., and Newton, J.C., Chromobacteriosis (Chro-mobacterium violaceum) in a 3 colobus monkeys (Colobus polykomos), J. Zoo Wildflife Med. 22, 476–484, 1991.
  • Kumar, M., Chaturvedi, V.K., and Singh, D.P., Chromobacterium violaceum, an unusual pathogen of swine, Indian Veter.J. 76, 869–871, 1999.
  • Laatsch, H.and Thomson, R.H., Spectro-scopic properties of violacein and related compound: crystal structure of tetramethylviolacein, J. Chem. Soc. Perkin Trans.II, 1331-1339, 1984.
  • Lawson, E.N., Barkhuisen, M., and Dew, D.W., Gold solubilization by the cyanide producing bacteria Chromobacterium violaceum, Process metall., 9A(Biohydrometallurgy and the Environment Toward the Mining of the 21st Century, Pt.A.) 239 (1999).
  • Lee, J., Kim, J.S., Nahm, C.H., Choi, J.W., Kim, J., Pai, S.H., Moon, K.H., Lee, K., and Chong, Y., Two cases of Chromobacte-rium violaceum infection after injury in a subtropical region, J. Clin. Microbiol. 37, 2068–2070, 1999.
  • Letendre C.H., Dickens, G., and Guroff, G., Tryptophan hydroxylase of Chromobac-terium violaceum, J. Biol. Chem. 249, 7186–7191, 1974.
  • Li, K.W., Wu, J., Xing, W.N., and Simon, J.A., Total synthesis of the antitumor depsipeptide FR-901, 228, J. Am. Chem. Soc. 118, 7237–7238, 1996.
  • Lichstein, H.C. and Van de Sand, V.F., Violacein an antibiotic pigment produced by Chromobacterium violaceum, J. Infect. Dis. 76, 47–51, 1945.
  • Liebergesell, M.Steinbuchel, A., and Steinbuechel, A., Production of poly:hydroxy-alkanoate polymer(s) — by culturing Chromatium vinosum or transformants containing C. vinosum PHA biosynthetic genes, Eur. Patent. WO 9302194-A1, 1993.
  • Liu, W.C., New aerocavin antibiotic — is (3E, 6E, 9E, 12 alpha, 14 beta)-12-hydroxy-14-(2-hydroxyundecyl)-10-methyl-2-oxo: oxa:cyclo:tetra:deca-3, 6, 9-tri:ene-4-acetic acid, US Patent US4686299-A, 1987.
  • Liu, C.H., Chu, R.M., Weng, C.N., Lin, Y.L., and Chi, C.S., An acute pleuropneumpnia in a pig caused by Chromobacterium violaceum, J. Compar. Pathol. 100, 459–463, 1989.
  • Macadam, A.M. and Knowles, C.J., Purification and properties of ?-cyano-L-alanine synthase from the cyanide producing bacterium Chromobacterium violaceum, Biochim. Biophys. Acta. 786, 123–132, 1984.
  • Macher, A.M., Casale, T.B., and Fauci, A.S., Chronic granulomatous disease of childhood and Chromobacterium violaceum infections in the southeastern, Ann. Intern. Med. 97, 51–55, 1982.
  • Macher, A.M., Casale, T.B., Gallin, J.I., Boltansky, H., and Fauci, A.S., Chromo-bacterium violaceum infectious and chronic granulomatous disease Ann. Intern. Med. 98, 259–259, 1983.
  • Machin-Villafranca, C., Ley, N., and Torres-Hernandez, L. Infección por Chro-mobacterium violaceum. Presentación de un caso com evolución fatal. Rev. Cubana Med. Trop. 38, 353–357, 1986.
  • Martin, J.and Brimacombe, J., Chromo-bacterium violaceum septicemia-The intensive care management of 2 cases, Anaethes. Intensive Care. 20, 88–90, 1992.
  • May, G., Brummer, B., and Ott, H., Purification of the antiviral compound violacein from cultures of Chromobacterium, Ger. Offen. DE 3935066, 1991.
  • Melo, P.S., Pigments from Chromobacterium violaceum and Serratia marcescens, (Haun, M, e Durán, N., Supervisors), M.Sc. Thesis, Institute of Biology, Universidade Estadual de Campinas, Brazil, 1996.
  • Melo, P.S., Haun, M., and Durán, N., In vitro evaluation of violacein toxicity in different cell lines, Proc. VII Panamerican Associastion of Biochemistry and Molecular Biology-PABMB, Chile, 1996.
  • Melo, P.S., MariaS.S., Vidal, BC., Haun, M., and Durán, N., Violacein cytotoxicity and induction of apoptosis in V79 cells. In vitro Cell. Dev. Biol. Animal. 36, 639–543, 2000.
  • Mergaert, J., Schirmer, A., Hauben, L., Mau, M., Hoste, B., Kersters, K., Jendrossek, D., and Swings, J., Isolation and identification of poly(3-hydroxyvalerate)-degrading strains of Pseudomonas lemoignei, Intern.J.Syst. Bacteriol. 46, 769–773, 1996.
  • McClean, K.H., Winson, M.K., Fish, L., Taylor, A., Chhabra, S.R., Camara, M., Daykin, M., Lamb, J.H., Swift, S., Bycroft, B.W., Stewart, G.S.A.B., and Williams, P., Quorum sensing and Chromobacterium violaceum: Exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones, Microbiology-UK, 143, 3703–3711, 1997.
  • McClure, H.M. and Chang, J., Chromobac-terium violaceum infection in a nonhuman primate (Macaca assamensis), Lab. Animal Sci. 26, 807–810, 1976.
  • Midani, S.and Rathore, M., Chromobacte-rium violaceum infection Southern Med.J.91, 464-466, 1998.
  • Miller, D.P., Blevins, W.T., Steele, D.B., and Stower, M.D., A comparative study of virulent and avirulent strains of Chromobac-terium violaceum, Can.J.Microbiol. 34, 249–255, 1988.
  • Momen, A.Z.M.R. and Hoshino, T., Biosynthesis of violacein: Intact incorporation of the tryptophan molecule on the oxindole side, with intramolecular rearrangement of the in-dole ring on the 5-hydroxyindole side, Biosci. Biotechnol. Biochem. 64, 539–549, 2000.
  • Momen, A.Z.M.R., Mizuoka, T., and Hoshino, T., Studies on the biosynthesis of violacein. Part 9. Green pigments possessing tetraindole and dipyrromethene moieties, chromoviridans and deoxychromoviridans, produced by a cell-free extract of Chromo-bacterium violaceum and their biosynthetic origins, J. Chem. Soc. Perkin Trans. 1, 3087–3092, 1998.
  • Mueller, A.and Zaehner, H., Metabolic products of microroganisms LXV. Ferrioxamines for Eubacteriales, Arch. Microbiol. 62, 257–260, 1968.
  • Murata, M., Towatari, M., Kosugi, H., Tanimoto, M., Ueda, R., Saito, H., and Naoe, T., Apoptotic cytotoxic effects of a histone deacetylase inhibitors, FK228, on malignant lymphoid cells, Jpn.J.Cancer Res. 91, 1154–1160, 2000.
  • Nakajima, H., Kim, Y.B., Terano, H., Yoshida, M., and Horinouchi, S., FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor, Experiment. Cell Res. 241, 126–133, 1998.
  • Nakata, H., Yamauchi, T., and Fujisawa, H., Phenylalanine hydroxylase from Chro-mobacterium violaceum, purification and characterization, J. Biol. Chem. 254, 1829–1833, 1979.
  • Ognibene, A.J. and Thomas, E., Fatal infection due to Chromobacterium violaceum in Vietnam, Am.J.Clin. Pathol. 54, 607–612, 1970.
  • Ohuchi, S., Okuyama, A., Naganawa, H., Kawamura, K., Aoyagi, T., and Umezawa, H., Isolation of two intermediates of arphamenine B biosynthesis, Meiji Seika Kenkyu Nenpo. 24, 44–47, 1985. Chem. Abstr. 106, 172650, 1997.
  • Onile, A., Sobowale, B.O., and Odugbemi, T., Human infection due to Chromobacte-rium violaceum. A report from Ilorin, Nigeria, East Afr. Med. J. 61, 849–852, 1984.
  • Onishi, A., Liotta, L.J., and Benkovic, S.J., Cloning and expression of Chromobacterium violaceum phenylalanine hydroxylase in Es-cherichia coli and comparison of amino acid sequence with mammalian aromatic amino acid hydroxylases, J. Biol. Chem. 266, 18454–18459, 1991.
  • Onishi, A., Liotta, L.J., and Benkovic, S.J., Chromobacterium violaceum phenylalanine hydroxylase gene, complete cds, NCBI-Pro-tein P30967; A40996; AAA23115; M55915, 1991.
  • Parker, W.L., Rathnum, M.L., Johnson, J.H., Wells, J.S., Principe, P.A., and Sykes, R.B., Aerocyanidin, a new antibiotic produced by Chromobacterium violaceun, J. Antibiotics. 41, 454–460, 1988.
  • Pember, S.O., Johnson, K.A., Villafranca, J.J., and Benkovic, S.J., Mechanistic studies on phenylalanine hydroxylase from Chromo-bacterium vlaceum. Evidence for the formation of an enzyme-oxygen complex, Biochemistry 28, 2124–2130, 1989.
  • Pember, S.O., Villafranca, J.J., and Benkovic, S.J., Chromobacterium violaceum phenylalanine 4-monooxygenase, Methods Enzymol. 142, 50–56, 1987.
  • Perberton, J.M., Vincent, K.M., and Penfold, R.J., Cloning and heterologous expression of the violacein biosynthesis gene cluster from Chromobacterium violaceum, Curr. Microbiol. 22, 355–358, 1991.
  • Petrillo, V.F., Severo, V., Santos, M.M., and Edelweiss, E.L., Recurrent infection with Chromobacterium violaceum: first case report from South America, J. Infect. 9, 167–169, 1984.
  • Ponte, R.and Jenkins, S.G., Fatal Chromo-bacterium violaceum infections associated with exposure to stagnant water, Pediatr. Infect. Dis. 11, 583–586, 1992.
  • Reilly, J.and Pyne, G., CXL. On the pigment produced by Chromobacterium violaceum, Biochem. J. 21, 1059–1064, 1927.
  • Ressler, C., Abe, O., Kondo, Y., Cottrell, B., and Abe, K., Purification and characterization from Chromobacterium violaceum of an enzyme catalyzing synthesis of ?-cyano-?-aminobutyric acid and thiocyanate, Biochemistry 12, 5369–5377, 1973.
  • Rettori, D., Production, extraction and purification of violacein: An antibiotic produced by Chromobacterium violaceum, (Durán, N., Supervisor), M.Sc. Thesis, Chemistry Institute, Universidade Estadual de Campinas, Brazil, 1996.
  • Rettori, D., Physico-chemical and biological studies of violacein:A pigment produced by Chromobacterium violaceum (Durán, N., Supervisor), Ph.D. Dissertation, Chemistry Institute, Universidade Estadual de Campinas, Brazil, 2000.
  • Rettori, D.and Durán, N., Stationary tray bioreactor for bacterial metabolites production, Brazilian Patent, PIBr 9702986-6, 1997.
  • Rettori, D.and Durán, N., Production, extraction and purification of violacein: an antibiotic produced by Chromobacterium violaceum, World.J.Microbiol. Biotechnol. 14, 685–688, 1998.
  • Richards, C., Chromobacterium violaceum, opportunistic pathogenic bacteria isolated in tropical and subtropical areas, Bull. Soc. Pathol. Exotique. 86, 169–173, 1993.
  • Richards, C., Chromobacterium violaceum, opportunistic pathogenic bacteria isolated in tropical and subtropical areas, Bull. Soc. Pathol. Exotique. 86, 307–307, 1993.
  • Riveros, R., Chemistry and biological activity of 1, 3-dihydro-2H-indole-2-one derivatives (Durán, N., Supervisor), M.Sc. Thesis, Chemistry Institute, Universidade Estadual de Campinas, Brazil, 1986.
  • Riveros, R., Bacterial chemistry: Biosynthesis and biological activity of Chromobacterium violaceum metabolites (Durán, N., Orientador). Ph.D. Dissertation, Chemistry Institute, Universidade Estadual de Campinas, 1989.
  • Riveros, R., Haun, M., Campos, V., and Durán, N., Bacterial chemistry-IV: Total characterization of violacein. An antibiotic try-panocide from Chromobacterium violaceum, Arq. Biol. Tecnol. 31, 475–487, 1988.
  • Riveros, R., Haun, M., and Durán, N., Bacterial chemistry-V: Effect of growth conditions on production of violascein by Chromo-bacterium violaceum BB-78 strain, BrazilianJ.Med. Biol. Res. 22, 569–577, 1989.
  • Roberts, S.A., Morris, A.J., McIvor, N., and EllisPegler, R., Chromobacterium violaceum infection of the deep neck tissues in a traveler to Thailand, Clin. Infect. Dis. 25, 334–335, 1997.
  • Sandor, V., Senderowicz, A., Mertins, S., Sackett, D., Sausville, E., Blagosklonny, M.V., and Bates, S.E., P21-dependent G(1) arrest with downregulation of cyclin D1 and upregulation od cyclin E by the histone deacetylase inhibitor FR901228, Br.J.Cancer. 83, 817–825, 2000.
  • Sandor, V., Robbins, A.R., Robey, R., Myers, T., Sauville, E., Bates, S.E., and Sackett, D.L., FR901228 causes mitotic arrest but does not alter microtubule polymerization, Anti-Cancer Drugs 11, 445–454, 2000.
  • Shigematsu, N., Ueda, H., Takase, S., Tanaka, H., Yamamoto, K., and Tada, T., FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No-968.2. Structure determination, J. Antibiotics. 47, 311–314, 1994.
  • Shirata, A., Tsukamoto, T., Yasui, H., Hata, T., Hayasaka, S., Kojima, A., and Kato, H., 148. Isolation of bacteria producing bluish-purple pigment and use for dyeing, Japan Agric. Res. Quart. 34, 131–140, 2000.
  • Shirazi-Beechey, S.P., Sraya, P., and Knowles, C.J., Serine hydroxymethyltransferase and gly-cine cleavage enzyme from the cyanogenic bacterium Chromobacterium violaceum, J. Gen. Microbiol. 130, 521–525, 1984.
  • Sherwood, M., Bacterial plastic comes to market, Bio/Technology. 1, 388–389, 1983.
  • Simo, F., Reuman, P.D., Martinez, F.J., and Ayoub, E.M., Chromobacterium violaceum as a cause of periorbital cellulitis, Pediatr. Infect. Dis. J. 3, 561–563, 1984.
  • Singh, P.D., Liu, W.C., Gougoutas, J.Z., Malley, M.F., Porubcan, M.A., Trejo, W.H., Wells, J.S., and Sykes, R.B., Aerocavin, a new antibiotic produced by Chromobacterium violaceum, J. Antibiotics. 41, 446–453, 1988.
  • Sippel, W.L., Medina, G., and Atwood, M.B., Outbreaks of disease in animals associated with Chromobacterium violaceum.1. The disease in swine, I. Am. Veter. Med. Assoc. 124, 467–471, 1954.
  • Sivendran, R.and Tan, S.H., Pathogenicity of nonpigmented cultures of Chromobacte-rium violaceum, J. Clin. Microbiol. 5, 514–516, 1977.
  • Smith, A.D. and Hunt, R.J., Solubilization of gold by Chromobacterium violaceum, J.Chem. Technol. Biotechnol.B.Biotechnol. 35, 110–116, 1985.
  • Sneath, P.H.A., Whelan, J.P.F., Singh, R.B., and Edwards, D., fatal infection by Chromo-bacterium violaceum, Lancet. 265, 276–277, 1953.
  • Snowe, R.J., Chromobacrterium violaceum, pathogenic for man, J.Infect. Dis. 123, 226–229, 1971.
  • Sorensen, R.U., Jacobs, M.R., and Shurin, S.B., Chromobacterium violaceum adenitis acquired in the northern United States as complication if chronic granulomatous disease, Pediat. Infect. Dis.J.4, 701-702, 1985.
  • Starr, A.J., Cribbett, L.S., Poklepovic, J., Freidman, H., and Ruffolo, E.H., Chromo-bacterium violaceum presenting as a surgical emergency, Southern Med.J. 74, 1137–1139, 1981.
  • Stenbuchel, A., Debzi, E.M., Marchessault, R.H., and Timm, A., Synthesis and production of poly(3-hydroxyvaleric acid) homopolyester by Chromobacterium violaceum, Appl. Microbiol. Biotechnol. 39, 443–449, 1993.
  • Steibuchel, A.and Schmack, G., Large-scale production of poly (3-hydrovaleric acid) by fermentation of Chromobacterium violaceum, processing, and characterization of the homopolyester, J. Environ. Polym. Degrad. 3, 243–258, 1995.
  • Ti, T.Y., Tan, W.C., Chong, A.P.Y., and Lee, E.H., Nonfatal and fatal infections caused by Chromobacterium violaceum, Clin. Infect. Dis. 17, 505–507, 1993.
  • Tobie, W.C., The pigment of Bacillus violaceusI.The production, extraction, and purification of violacein, J. Bacteriol. 29, 223–227, 1934.
  • Tucker, R.E., Winter, W.G., and Wilson, H.D., Osteomyelitis associated with Chro-mobacterium violaceum sepsis-case-report, J. Bone Joint Sur. Am. Vol. 61, 949–951, 1979.
  • Turner, S.J., Lewis, G.D., Saul, D.J., Baker, C.S., and Rodrigo, A.G., Chromobacterium violaceum 16S ribosomal RNA gene, partial sequence spanning the V3-V4 regions, NCBI-Nucleotide. U65966, 1996.
  • Ueda, H., Nakajima, H., Hori, Y., Fujita, T., Nishimura, M., Goto, T., and Okuhara, M., FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No968.1. Taxonomy, fermentation, isolation, physicochemical and biological properties, and antitumor activity, J.Antibiotics. 47, 301–310, 1994.
  • Ueda, H., Nakajima, H., Hori, Y., Goto, T., and Okuhara, M., Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No968, on Ha-Ras transformed NIH3T3 cells, Biosci. Biotecnol. Biochem. 58, 1579–1583, 1994.
  • Vinogradov, E.V., Brade, H., and Holst, O., The structure of the O-specific polysaccharide of the lipopolysaccharide from Chromobacte-rium violaceum NCT9694, Carbohydr. Res. 264, 313–317, 1994.
  • Volner, A., Sam, M., and Han, A.Y., Chro-mobacterium violaceum phenylalanine hy-droxylase: cloning, purification, and iron-dependent catalysis. Abstr. Papers Am. Chem. Soc. 219, 505–505, 2000.
  • Volner, A., Nersissian, A.M., and Abu-Omar, M.M., Chromobacterium violaceum phenylhydroxylase gene, complete cds, NCBI-Protein. AAD37774; AF146711, 1999.
  • Wells, J.C., Trejo, W.H., Principe, P.A., Georgopapadakou, N., Bush, K., Bonner, D.P., and Sykes, R.B., SQ 26, 180, a novel monobactam.I.Taxonomy, fermentation and biological properties, J. Antibiotics. 35, 184–188, 1982.
  • Wijewant, E.A. and Wettimun, S.G., Chro-mobacterium violaceum infection in pigs, Res. Veter. Sci. 10, 389–391, 1969.
  • Wilkey, I.S. and McDonald, A., A probable case of Chromobacterium violaceum infection in Australia, Med.J.Austr. 2, 39–40, 1983.
  • Wooley, P.G., Bacillus violaceus manilae (a pathogenic organism), Bull. Johns Hopkins Hosp. 16, 89-90, 1905.
  • Yamanouchi Pharm. Ltd., Antimicrobial agent — containing. 6-hydroxy-3-oxo-1, 2-benzisoxaline as active component, JP Patent JP58072519-A; JP58052277-A, 1983.
  • Yu, T.S. and Kim, T.H., Purification and properties of extracellular cytosine deaminase from Chromobacterium violaceum YK 391, J. Microbiol. Biotechnol. 9, 173–178, 1999.
  • Zii Biseibutsu Kagaku Ken, Alphamenine A or B analgesics enhance analgesic effect of morphine, obtained from Chromobacterium violaceum, Patent JP 59144717-A, 1984.
  • Zimmerman, B., Review of Bergonzini on Cromobacterium, Bot. Centralbl. 4, 1528–1530, 1881.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.